David Rescott
Stock Analyst at Baird
(3.88)
# 548
Out of 4,829 analysts
58
Total ratings
57.14%
Success rate
7.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Maintains: Outperform | $55 → $61 | $44.06 | +38.45% | 4 | May 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $95.83 | +14.79% | 3 | Apr 25, 2025 | |
| PEN Penumbra | Maintains: Buy | $315 → $330 | $297.32 | +10.99% | 29 | Apr 24, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $72 → $75 | $73.68 | +1.79% | 4 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $115 → $120 | $102.86 | +16.66% | 5 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $536.51 | +7.17% | 3 | Apr 23, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $91 | $83.48 | +9.01% | 4 | Feb 19, 2025 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $18.49 | +40.62% | 6 | Dec 22, 2023 |
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $44.06
Upside: +38.45%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $95.83
Upside: +14.79%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $315 → $330
Current: $297.32
Upside: +10.99%
Edwards Lifesciences
Apr 24, 2025
Maintains: Neutral
Price Target: $72 → $75
Current: $73.68
Upside: +1.79%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $115 → $120
Current: $102.86
Upside: +16.66%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $536.51
Upside: +7.17%
Medtronic
Feb 19, 2025
Maintains: Neutral
Price Target: $90 → $91
Current: $83.48
Upside: +9.01%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $18.49
Upside: +40.62%